Sign inCreate account

Report workspace tools

NCT04190004COMPLETEDanonymous

Effect of Intranasal Vasopressin on Cooperative Behavior in Schizophrenia

Sponsor

Source record

National Institute of Mental Health and Neuro Sciences, India

Phase

Source record

NA

Modality

AI-normalized

RNA therapy

Target

AI-normalized

Cooperative behavior in schizophrenia

Indication / condition

AI-normalized

Schizophrenia

Intervention

Source record

Vasopressins, Placebo

Source & freshness

Source record

NCT ID

NCT04190004

Original source

ClinicalTrials.gov

Source last updated

Dec 09, 2019

Ingested at

May 30, 2026

Internal sync

Jun 05, 2026

Model version

trialsignal-ai-v1

Normalized confidence

88%

Validation status

validated

Open original registry record
View original source fields

NCT ID

NCT04190004

Title

Effect of Intranasal Vasopressin on Cooperative Behavior in Schizophrenia

Sponsor

National Institute of Mental Health and Neuro Sciences, India

Status

COMPLETED

Phase

NA

Condition raw

Schizophrenia

Condition normalized

Schizophrenia

Modality raw

Schizophrenia

Modality normalized

RNA therapy

Target raw

Cooperative behavior in schizophrenia

Target normalized

Cooperative behavior in schizophrenia

Interventions

Vasopressins, Placebo

Public preview

Source record

This completed interventional study evaluated the effects of intranasal vasopressin on cooperative behavior in patients diagnosed with schizophrenia. The study involved a randomized, double-masked, crossover design with 30 participants, assessing behavioral performance in economic games.

AI-generated analysis supports research triage only. Verify source records, publications, sponsor disclosures and IP databases before making diligence decisions. Model: trialsignal-ai-v1.

Report access

Create an account to unlock this report

Choose the access model that matches the job: one urgent report, reusable credits for project work, or unlimited monthly access with AI and folders.

Full protocol, outcomes, eligibility, contacts and results sections
Patent/IP landscape with verified records when available
Board-ready PDF export with source provenance
Save to folders and synthesize multiple assets in premium workspace
Create account
Sign in

Create a free account first, then unlock a single report, buy credits or subscribe.

TrialSignal

Clinical trial intelligence report

Effect of Intranasal Vasopressin on Cooperative Behavior in Schizophrenia

Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.

Generated

Jun 13, 2026

NCT ID

NCT04190004

Status

COMPLETED

Phase

NA

Sponsor

National Institute of Mental Health and Neuro Sciences, India

Executive brief

Investment-Ready Snapshot

This completed interventional study evaluated the effects of intranasal vasopressin on cooperative behavior in patients diagnosed with schizophrenia. The study involved a randomized, double-masked, crossover design with 30 participants, assessing behavioral performance in economic games.

Source & freshness

Provenance

SourceClinicalTrials.gov
Source updatedDec 09, 2019
Internal syncJun 05, 2026
Model versiontrialsignal-ai-v1

https://clinicaltrials.gov/study/NCT04190004

Indication

Schizophrenia

Modality

RNA therapy

Target

Cooperative behavior in schizophrenia

Intervention

Vasopressins, Placebo

Source record

Protocol Description

Detailed source ingestion pending.

Source record

Outcome Measures

Detailed source ingestion pending.

Source record

Eligibility

Detailed source ingestion pending.

AI analysis

Known Results And Readout Context

Detailed source ingestion pending.

IP intelligence

Patent And IP Landscape

Detailed source ingestion pending.

Source record

Contacts

Detailed source ingestion pending.